Next-Generation Biologics for Sustained HIV Remission (R01)

קרןNational Institutes of Health (NIH)
סוגResearch Grants
תאריך אחרון27/07/2018
פקולטהLife Sciences, Medicine

This grant solicits applications that support research on and early development of next‑generation biologics with the goal of inducing sustained HIV remission. 


Funding: $500,000 per year 

Duration: 5 years 


Research Authority due date: 20.6.18

LOI (encouraged) due date: 27.6.18

Full proposal due date: 27.7.18

קבצים מצורפים
עדכון אחרוןעדכון אחרון: 12/04/2018
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive